482 related articles for article (PubMed ID: 16362881)
1. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N
J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881
[TBL] [Abstract][Full Text] [Related]
2. Citropin 1.1-treated central venous catheters improve the efficacy of hydrophobic antibiotics in the treatment of experimental staphylococcal catheter-related infection.
Cirioni O; Giacometti A; Ghiselli R; Kamysz W; Orlando F; Mocchegiani F; Silvestri C; Licci A; Chiodi L; Lukasiak J; Saba V; Scalise G
Peptides; 2006 Jun; 27(6):1210-6. PubMed ID: 16289474
[TBL] [Abstract][Full Text] [Related]
3. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis.
Giacometti A; Cirioni O; Ghiselli R; Dell'Acqua G; Orlando F; D'Amato G; Mocchegiani F; Silvestri C; Del Prete MS; Rocchi M; Balaban N; Saba V; Scalise G
Peptides; 2005 Feb; 26(2):169-75. PubMed ID: 15629527
[TBL] [Abstract][Full Text] [Related]
4. Comparative efficacies of quinupristin-dalfopristin, linezolid, vancomycin, and ciprofloxacin in treatment, using the antibiotic-lock technique, of experimental catheter-related infection due to Staphylococcus aureus.
Giacometti A; Cirioni O; Ghiselli R; Orlando F; Mocchegiani F; Silvestri C; Licci A; De Fusco M; Provinciali M; Saba V; Scalise G
Antimicrob Agents Chemother; 2005 Oct; 49(10):4042-5. PubMed ID: 16189078
[TBL] [Abstract][Full Text] [Related]
5. Distinctin improves the efficacies of glycopeptides and betalactams against staphylococcal biofilm in an experimental model of central venous catheter infection.
Giacometti A; Cirioni O; Ghiselli R; Orlando F; Silvestri C; Renzone G; Testa I; Mocchegiani F; Della Vittoria A; Saba V; Scaloni A; Scalise G
J Biomed Mater Res A; 2007 Apr; 81(1):233-9. PubMed ID: 17120214
[TBL] [Abstract][Full Text] [Related]
6. RNAIII-inhibiting peptide in combination with the cathelicidin BMAP-28 reduces lethality in mouse models of staphylococcal sepsis.
Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Bergnach C; Orlando F; Mocchegiani F; Silvestri C; Skerlavaj B; Licci A; Balaban N; Zanetti M; Scalise G; Saba V
Shock; 2006 Sep; 26(3):296-301. PubMed ID: 16912656
[TBL] [Abstract][Full Text] [Related]
7. Pretreatment with the protegrin IB-367 affects Gram-positive biofilm and enhances the therapeutic efficacy of linezolid in animal models of central venous catheter infection.
Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Silvestri C; Orlando F; Kamysz W; Licci A; Nadolski P; Della Vittoria A; Łukasiak J; Scalise G; Saba V
JPEN J Parenter Enteral Nutr; 2007; 31(6):463-8. PubMed ID: 17947600
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model.
LaPlante KL; Mermel LA
Nephrol Dial Transplant; 2007 Aug; 22(8):2239-46. PubMed ID: 17403700
[TBL] [Abstract][Full Text] [Related]
9. Suppression of drug-resistant Staphylococcal Infections by the quorum-sensing inhibitor RNAIII-inhibiting peptide.
Dell'Acqua G; Giacometti A; Cirioni O; Ghiselli R; Saba V; Scalise G; Gov Y; Balaban N
J Infect Dis; 2004 Jul; 190(2):318-20. PubMed ID: 15216467
[TBL] [Abstract][Full Text] [Related]
10. BisEDT and RIP act in synergy to prevent graft infections by resistant staphylococci.
Domenico P; Gurzenda E; Giacometti A; Cirioni O; Ghiselli R; Orlando F; Korem M; Saba V; Scalise G; Balaban N
Peptides; 2004 Dec; 25(12):2047-53. PubMed ID: 15572191
[TBL] [Abstract][Full Text] [Related]
11. Use of the quorum-sensing inhibitor RNAIII-inhibiting peptide to prevent biofilm formation in vivo by drug-resistant Staphylococcus epidermidis.
Balaban N; Giacometti A; Cirioni O; Gov Y; Ghiselli R; Mocchegiani F; Viticchi C; Del Prete MS; Saba V; Scalise G; Dell'Acqua G
J Infect Dis; 2003 Feb; 187(4):625-30. PubMed ID: 12599079
[TBL] [Abstract][Full Text] [Related]
12. Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice.
Kokai-Kun JF; Chanturiya T; Mond JJ
J Antimicrob Chemother; 2009 Jul; 64(1):94-100. PubMed ID: 19398455
[TBL] [Abstract][Full Text] [Related]
13. RNAIII-inhibiting-peptide-loaded polymethylmethacrylate prevents in vivo Staphylococcus aureus biofilm formation.
Anguita-Alonso P; Giacometti A; Cirioni O; Ghiselli R; Orlando F; Saba V; Scalise G; Sevo M; Tuzova M; Patel R; Balaban N
Antimicrob Agents Chemother; 2007 Jul; 51(7):2594-6. PubMed ID: 17116671
[TBL] [Abstract][Full Text] [Related]
14. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci.
Lee JY; Ko KS; Peck KR; Oh WS; Song JH
J Antimicrob Chemother; 2006 Jun; 57(6):1110-5. PubMed ID: 16556639
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of linezolid, vancomycin, gentamicin and ciprofloxacin in a rabbit model of antibiotic-lock technique for Staphylococcus aureus catheter-related infection.
Fernández-Hidalgo N; Gavaldà J; Almirante B; Martín MT; Onrubia PL; Gomis X; Pahissa A
J Antimicrob Chemother; 2010 Mar; 65(3):525-30. PubMed ID: 20083550
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis.
Ha KR; Psaltis AJ; Butcher AR; Wormald PJ; Tan LW
Laryngoscope; 2008 Mar; 118(3):535-40. PubMed ID: 18090864
[TBL] [Abstract][Full Text] [Related]
17. Model of Staphylococcus aureus central venous catheter-associated infection in rats.
Ulphani JS; Rupp ME
Lab Anim Sci; 1999 Jun; 49(3):283-7. PubMed ID: 10403443
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Gov Y; Kamysz W; Lukasiak J; Mocchegiani F; Orlando F; D'Amato G; Balaban N; Saba V; Scalise G
Circulation; 2003 Aug; 108(6):767-71. PubMed ID: 12885754
[TBL] [Abstract][Full Text] [Related]
19. In vitro effectiveness of the antibiotic lock technique (ALT) for the treatment of catheter-related infections by Pseudomonas aeruginosa and Klebsiella pneumoniae.
Lee MY; Ko KS; Song JH; Peck KR
J Antimicrob Chemother; 2007 Oct; 60(4):782-7. PubMed ID: 17681978
[TBL] [Abstract][Full Text] [Related]
20. A simple infection model using pre-colonized implants to reproduce rat chronic Staphylococcus aureus osteomyelitis and study antibiotic treatment.
Monzón M; García-Alvarez F; Laclériga A; Gracia E; Leiva J; Oteiza C; Amorena B
J Orthop Res; 2001 Sep; 19(5):820-6. PubMed ID: 11562127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
